Need help? Our team of experienced experts is here for you with full support.
AKA-73
Apremilast
Cat. No.
AKA-73
CAS No.
608141-41-9
MF
C22H24N2O7S
MW
460.5
Apremilast is an inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4).
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Storage and Shipping
References
Product Name
Apremilast
CAS No.
608141-41-9
MF
C22H24N2O7S
MW
460.5
Specification
98%
Description
Apremilast is an inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4). Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: In Stock
Documents
Certificate of Analysis (COA), API specification, Safety Data Sheet (SDS/MSDS), evidence of GMP compliance, Stability data / Stability summary, etc.
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Perez-Aso M, et al. Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors. Arthritis Research & Therapy. 2015 Sep 15;17:249. PMID: 26370839
[2]. Chen LG, et al. Determination of Apremilast in Rat Plasma by UPLC-MS-MS and Its Application to a Pharmacokinetic Study. Journal of Chromatographic Science. 2016 Sep;54(8):1336-40. PMID: 27165568
[2]. Chen LG, et al. Determination of Apremilast in Rat Plasma by UPLC-MS-MS and Its Application to a Pharmacokinetic Study. Journal of Chromatographic Science. 2016 Sep;54(8):1336-40. PMID: 27165568
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.